coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Arun Integrated Care (aic) PCN Ltd, Arun · Health Inequalities Profile

    PCN U21339 · NHS Surrey and Sussex Integrated Care Board; NHS Sussex Integrated Care Board · 3 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    35,711

    Registered population

    51.6% aged 18–64

    32.1%

    Aged 65+

    ICB 21.9% · England 17.9%

    4.3%

    Ethnic minority (non-White)

    1.7% Asian · England 9.6%

    7.5%

    In IMD quintile 1

    ICB 9.2% · England 21.0%

    ~2,435

    Core20 residents (est.)

    Resident basis; registered basis ~2,411 · see page 3

    7,733

    Hypertension register

    +7.22% in 3 yrs · England +5.60%

    312

    SMI register

    15.6% of Arun's

    856

    COPD register

    Reviews -9.50% in 3 yrs

    Forecast to 2030

    9,122

    Hypertension patients, 2030

    +1,389 on today

    74.8%

    QRISK ≥20% on statins, 2030

    +4.49pp over 3 yrs

    7.4%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    -9.5%
    Annual COPD reviews fell while England rose.

    Over 2023 to 2025, COPD reviews fell 9.5% (England +2.8%) to 72.7% (England 76.4%), which may reflect review capacity and remains unverified locally.

    65.1%
    Under-80 blood pressure control lags England.

    Control is 65.1% (England 67.8%), with -2.5% 3-year change (England +3.2%); Westcourt Medical Centre is 59.9%, while Willow Green Surgery reaches 71.2%.

    92.7%
    Mental health physical checks rose well above England.

    Over 2023 to 2025, blood pressure checks rose +17.8 pp to 92.7% (England 83.4%) and BMI checks reached 91.9% (England 82.1%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Of 35,711 patients, 32.1% are aged 65+ alongside 36 catchment care homes

    Across 35,711 registered patients, 32.1% (11,449) are aged 65+, above Arun (29.2%), NHS Sussex Integrated Care Board (21.9%) and England (17.9%). Working-age adults (18-64) form 51.6% (Arun 54.9%; ICB 60.5%; England 62.7%) and children (0-17) form 16.4% (Arun 15.9%; ICB 17.7%; England 19.6%). Census resident estimates show 95.7% White ethnicity (Arun 95.8%; ICB 91.0%; England 81.1%) and 4.3% ethnic minority, not registered-patient counts. Despite this older profile, recorded dementia fell 1.5% over 2023 to 2025 (Arun +5.6%; ICB +2.2%; England +6.0%) to 1.2% (441 patients), which could reflect coding changes; register audits would test this.

    Age profile

    0–1716.4%
    18–6451.6%
    65+32.1%

    65+: ICB 21.9%, England 17.9%

    Ethnicity

    White95.7%
    Mixed1.7%
    Asian1.7%
    Black0.6%
    Other0.4%

    Older people · falls rows are Arun local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Arun LA)2,3272,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)77.6%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)61.8%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Arun LA)1,2169819552024/25
    Falls deaths, all ages, per 100,000 (Arun LA)13.314.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation affects 7.5% of PCN patients and concentrates entirely in Park Surgery

    Across the PCN, 7.5% of registered patients live in Core20 areas, below Arun (9.8%), NHS Sussex Integrated Care Board (9.2%) and England (21.0%). A 0.74 percentage point reconciliation difference exists between the PCN rate and the 6.8% weighted practice share. Deprivation is entirely concentrated at Park Surgery, with a 21.5% Core20 share (an estimated 2,411 patients), while Westcourt Medical Centre and Willow Green Surgery record 0.0%. Prioritising proactive chronic disease reviews and inclusion support at Park Surgery directs Core20 resources to the only practice serving this population.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Park21.5% · 2,411 patients
    Westcourt0.0% · 0 patients
    Willow Green0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    312

    SMI register

    0.88% recorded prevalence

    204

    Learning disability register

    0.57% recorded prevalence

    36

    Care homes, 1,249 beds

    In the PCN catchment

    8.9%

    Provide unpaid care

    Arun, Census 2021

    The PCN records 204 learning disability patients (0.6%; Arun 0.8%; ICB 0.6%; England 0.6%) and 312 severe mental illness patients (0.9%; Arun 1.1%; ICB 1.1%; England 1.0%), alongside 36 catchment care homes (1,249 beds). In Arun, 16 people slept rough in autumn 2025 and 8.9% provide unpaid care (Census 2021). The gap against Arun's learning disability rate could reflect recording differences, which register searches would test.

    Severe mental illness: physical health checks

    Recorded SMI checks reach 92.7% for blood pressure and 91.9% for BMI, exceeding England (83.4% and 82.1%). Smoking cessation support is 93.5% (England 94.2%), but stands at 83.1% at Westcourt Medical Centre, which may warrant targeted review.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    7,733

    Hypertension register

    +7.22%

    Register growth, 3 yrs

    Arun +4.55% · England +5.60%

    −1.64pp

    BP control, under 80

    ≤140/90 · −0.66pp aged 80+

    +1,389

    More patients by 2030

    Forecast 9,122 (25.01%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 21.8% (7,733 patients), above England (15.2%), Arun (19.8%), and NHS Sussex Integrated Care Board (16.3%). While 90.9% of hypertension patients have a recent blood pressure reading (England 90.0%), blood pressure control in patients aged under 80 fell 2.5% over 2023 to 2025 (England +3.2%) to 65.1% (England 67.8%), and control in those aged 80+ fell 0.8% (England +2.2%) to 78.4% (England 81.2%). Across practices, under-80 control ranges from 59.9% at Westcourt Medical Centre to 71.2% at Willow Green Surgery. Lower blood pressure control against England across both age cohorts may reflect differences in medication titration or review recall, which local audit could test, particularly at Westcourt Medical Centre.

    Lipids and statins

    For primary prevention, 64.8% of patients with QRISK ≥ 20% receive lipid-lowering therapy, above England (63.6%). However, in secondary prevention, 82.2% of diabetic patients with cardiovascular disease receive statins, trailing England (84.4%). Secondary prevention statin coverage trails England, which may warrant reviewing recall systems for diabetic patients with cardiovascular disease.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202684,351£2.80£2.42£1.86£236,183
    Cardiovascular (all), 2025107,403£3.29£3.32£3.33£353,356

    In 2026, the PCN spent £2.80 per item on lipid-modifying drugs across 84,351 items, compared with £1.86 in England and £2.42 in NHS Sussex Integrated Care Board, representing £79,290 more than at England's unit cost. Higher unit cost than England may reflect formulary choices, though unit cost does not establish efficiency or clinical appropriateness.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +5.94%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +4.05%

    Asthma prevalence, PCN 3-yr % change

    COPD prevalence is 2.4% (856 patients; England 1.9%) after rising +5.5% over 2023 to 2025 (England +2.6%). Annual COPD reviews fell 9.5% over 2023 to 2025 (England +2.8%) to 72.7%, below Arun (74.5%) and England (76.4%), which could reflect review capacity. Asthma prevalence is 8.7% (2,963 patients; England 6.6%), with 66.0% reviewed in the last 12 months, leaving an estimated scale gap of 1,007 patients. Asthma prescribing for ages 5-19 is 1,985 items per 1,000 (England 1,488).

    Cancer register and children's immunisation

    Cancer prevalence is 6.1% (2,169 patients; England 3.8%). In childhood immunisations, 6-in-1 coverage at 12 months reaches 97.3% (England 91.0%), but 4-in-1 pre-school booster coverage at age 5 is 93.1%, below the 95.0% target by 1.9 pp. MMR second-dose coverage at age 5 is 94.8% (first dose 96.6%), with Westcourt Medical Centre recording a 5.9 pp dose difference between first dose (94.1%) and second dose (88.2%).

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months97.3%

    England 91.0%

    6-in-1 complete primary course at 24 months94.9%

    England 92.2%

    MMR dose 1 at 24 months93.6%

    England 88.3%

    MMR dose 2 at age 594.8%

    England 82.8%

    4-in-1 pre-school booster at age 593.1%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    58.5%

    Sussex ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,360

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Sussex ICBEnglandNo usable stageStaged cancers
    Prostate56.6%53.2%19%1,668
    Breast86.1%85.4%23%1,400
    Bowel49.8%47.0%26%1,133
    Lung30.3%33.8%15%1,058
    Skin cancer95.3%87.8%17%698

    Across NHS Sussex ICB in 2022, 58.5% of cancers with a known stage (4,799 of 8,209) were diagnosed at stage 1 or 2, exceeding England (55.3%) but remaining 16.5 pp below the 75.0% national ambition by 2028. Known-stage completeness was 64.3% (8,209 of 12,766; England 67.0%), meaning unrecorded staging restricts certainty. Sizing this ICB gap indicates an extra 1,357.8 (about 1,360) early-stage cases annually are needed to meet 75.0%. Within the PCN, recorded cancer prevalence is 6.1% (2,169 patients; England 3.8%), alongside cervical screening at 74.5% (England 66.8%) and breast screening at 75.4% (England 69.9%). Maintaining high screening uptake across member practices supports early detection across the PCN.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In Jul 2026 (provisional), University Hospitals Sussex NHS Foundation Trust achieved 65.2% on the 62-day cancer referral to treatment standard, 19.8 pp below the 85.0% standard, trailing Portsmouth Hospitals University NHS Trust (75.2%), Royal Surrey NHS Foundation Trust (84.5%), NHS Surrey and Sussex Integrated Care Board (71.5%) and England (71.2%). Its 31-day combined treatment was 76.8% (standard 96.0%) and 28-day faster diagnosis was 74.0% (standard 75.0%). In diagnostic waits, 12.9% waited 6+ weeks overall, though colonoscopy reached 39.3% (England 30.8%). Acute waiting pressures may prolong diagnostic resolution for referred PCN patients.

    Pathways within standard (%)SussexPortsmouthRoyal SurreySurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)74.0166.8182.6279.2979.32
    31-day treatment (96%)76.7994.7896.4390.4592.50
    62-day referral to treatment (85%)65.2075.2084.4871.5171.16
    Diagnostic waits over 6 weeks (%)SussexPortsmouthRoyal SurreyEngland
    MRI5.6250.360.0021.40
    CT8.5713.060.159.92
    Echocardiography0.3932.751.5528.48
    Colonoscopy39.3582.520.0030.83
    Gastroscopy20.0274.880.0029.02
    All 15 DM01 tests12.9551.968.8223.14
    Community services activityWest Sussex residentsSurrey and Sussex ICB
    Care contacts78,050309,615
    Referrals16,01566,930
    Patients with a contact19,77085,660

    Community services (residents of West Sussex), Jun 2026 (provisional). In Jun 2026 (provisional experimental data), 19,770 West Sussex residents had 78,050 community care contacts, and adults aged 65+ accounted for 72.7% of them (56,740). NHS Surrey and Sussex Integrated Care Board recorded 309,615 contacts across 85,660 patients. High older-age community contacts point to significant opportunities for joint proactive review with local community teams.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Overall QOF achievement is high, but vaccination domain achievement varies widely across practices

    Overall QOF achievement exceeds England (92.5%) across all three practices, reaching 93.9% at Park Surgery, 95.3% at Westcourt Medical Centre, and 98.8% at Willow Green Surgery. Clinical achievement is also high (97.2% at Park Surgery, 100.0% at Willow Green Surgery). However, vaccination achievement spans a 28.4 pp range, from 61.8% at Westcourt Medical Centre to 90.2% at Willow Green Surgery.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Westcourt800.052.8%72.8%86.9%
    Willow Green1030.072.7%60.1%79.9%
    Park Surgery10421.560.8%46.3%77.4%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNArunAssetPCNArun
    Care homes (catchment)36 (1,249 beds)n/aSchools (catchment)29n/a
    Children's centres37Places of worship1968
    Libraries37Homelessness support (VCS)0no data
    Day centres (VCS)n/a1Carers support groups (VCS)n/a1
    Primary schools (LA maintained)321Primary academies819
    Special schools11

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Target age-five booster recall

    At age 5 in Q1 2025/26, MMR coverage drops 5.9 pp from first (94.1%) to second dose (88.2%) at Westcourt Medical Centre (PCN drop 1.8 pp, 96.6% to 94.8%); PCN 4-in-1 coverage is 93.1% (below 95.0% by 1.9 pp). Low cost, quick to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Option 2

    Review lipid-modifying prescribing formulary

    In 2026, the PCN spent £2.80 per item on lipid-modifying drugs across 84,351 items versus £1.86 in England and £2.42 in NHS Sussex Integrated Care Board, spending £79,290 more than at England's unit cost. Low cost, quick to run.

    Evidence base: tracks pharmacological uptake of hypertension case-finding and BP control; rising volume with falling admissions is the success signal.

    Policy anchor: Core20PLUS5 adults: hypertension case-finding and optimal management (CVD); Modern service frameworks for CVD, frailty and dementia, severe mental illness.

    Option 3

    Expand structured annual asthma reviews

    Of 2,963 asthma register patients (8.7%; England 6.6%), 66.0% had a review in the last 12 months (England 65.7%), an estimated scale gap of 1,007 patients alongside 1,985 asthma items per 1,000 aged 5-19 (England 1,488). Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Dementia register coding audit (p2)Dementia register66.7% diagnosis ambition · 95% care plan 2027PCN
    Targeted Core20 chronic disease outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Targeted smoking cessation review (p4)Smoking cessation support and treatment offered to patients with certain conditions (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Hypertension titration protocol review (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Preschool immunisation recall and outreach (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Option 1 · Target age-five booster recall (p12)MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 5 · 4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Option 2 · Review lipid-modifying prescribing formulary (p12)Cost per item for Lipid-regulating drugs 2026 · Count of Items prescribed for Lipid-regulating drugs 2026Core20PLUS5 approach · Neighbourhood health frameworkPCN
    Option 3 · Expand structured annual asthma reviews (p12)Asthma register · Asthma: QOF prevalence · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15